CIPOLLINI, MONICA Statistiche
CIPOLLINI, MONICA
DIPARTIMENTO DI BIOLOGIA
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people
2014-01-01 Garritano, SONIA IOLANDA; DE SANTI, Chiara; Silvestri, R; Melaiu, Ombretta; Cipollini, Monica; Barone, Elisa; Lucchi, Marco; Barale, Roberto; Mutti, L; Gemignani, Federica; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Landi, Stefano
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma
2016-01-01 Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Melaiu, Ombretta; Cipollini, Monica; Bambi, Franco; Chen, Bowang; Köhler, Aleksandra; Cristaudo, Alfonso; Hemminki, Kari; Gemignani, Federica; Försti, Asta; Landi, Stefano
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
2016-01-01 Pellè, Lucia; Cipollini, Monica; Tremmel, Roman; Romei, Cristina; Figlioli, Gisella; Gemignani, Federica; Melaiu, Ombretta; DE SANTI, Chiara; Barone, Elisa; Elisei, Rossella; Seiser, Eric; Innocenti, Federico; Zanger, Ulrich M.; Landi, Stefano
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review.
2017-01-01 Cipollini, Monica; Landi, Stefano; Gemignani, Federica
Correction: Inherited variants in genes somatically mutated in thyroid cancer
2018-01-01 Campo, Chiara; Köhler, Aleksandra; Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Bambi, Franco; Hemminki, Kari; Gemignani, Federica; Landi, Stefano; Försti, Asta
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
2017-01-01 DE SANTI, Chiara; Melaiu, Ombretta; Bonotti, Alessandra; Cascione, Luciano; Di Leva, Gianpiero; Foddis, Rudy; Cristaudo, Alfonso; Lucchi, Marco; Mora, Marco; Truini, Anna; Tironi, Andrea; Murer, Bruno; Boldorini, Renzo; Cipollini, Monica; Gemignani, Federica; Gasparini, Pierluigi; Mutti, Luciano; Landi, Stefano
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
2021-01-01 Dell'Anno, I.; Martin, S. A.; Barbarino, M.; Melani, A.; Silvestri, R.; Bottaro, M.; Paolicchi, E.; Corrado, A.; Cipollini, M.; Melaiu, O.; Giordano, A.; Luzzi, L.; Gemignani, F.; Landi, S.
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma
2011-01-01 Cancemi, Lisa; Romei, Cristina; Bertocchi, Sara; Tarrini, Giulia; Spitaleri, Irene; Cipollini, Monica; Landi, Debora; Garritano, Sonia; Pellegrini, Giovanni; Cristaudo, Alfonso; Pinchera, Aldo; Barale, Roberto; Elisei, Rossella; Landi, Stefano; Gemignani, Federica
Expression status of candidate genes in mesothelioma tissues and cell lines
2015-01-01 Melaiu, Ombretta; Melissari, E; Mutti, L; Bracci, E; DE SANTI, Chiara; Iofrida, C; Di Russo, M; Cristaudo, Alfonso; Bonotti, Alessandra; Cipollini, Monica; Garritano, Si; Foddis, Rudy; Lucchi, Marco; Pellegrini, Silvia; Gemignani, Federica; Landi, Stefano
Genome-wide association study on differentiated thyroid cancer.
2013-01-01 Köhler, A; Chen, B; Gemignani, Federica; Elisei, Rossella; Romei, Cristina; Figlioli, G; Cipollini, Monica; Cristaudo, Alfonso; Bambi, F; Hoffmann, P; Herms, S; Kalemba, M; Kula, D; Harris, S; Broderick, P; Houlston, R; Pastor, S; Marcos, R; Velázquez, A; Jarzab, B; Hemminki, K; Landi, Stefano; Försti, A.
High prevalence of chromosome 10 rearrangements in human lymphocytes after in vitro X-ray irradiation
2000-01-01 Scarpato, Roberto; Lori, A.; Tomei, ANTONIO EGIDIO; Cipollini, Monica; Barale, Roberto
Inherited variants in genes somatically mutated in thyroid cancer
2017-01-01 Campo, Chiara; Kohler, Aleksandra; Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Bambi, Franco; Hemminki, Kari; Gemignani, Federica; Landi, Stefano; Forsti, Asta
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
2017-01-01 Melaiu, Ombretta; Catalano, Calogerina; DE SANTI, Chiara; Cipollini, Monica; Figlioli, Gisella; Pellè, Lucia; Barone, Elisa; Evangelista, Monica; Guazzelli, Alice; Boldrini, Laura; Sensi, Elisa; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Mutti, Luciano; Fontanini, Gabriella; Gemignani, Federica; Landi, Stefano
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals
2017-01-01 DE SANTI, Chiara; Pucci, Perla; Bonotti, Alessandra; Melaiu, Ombretta; Cipollini, Monica; Silvestri, Roberto; Vymetalkova, Veronika; Barone, Elisa; Paolicchi, Elisa; Corrado, Alda; Lepori, Irene; Dell'Anno, Irene; Pellè, Lucia; Vodicka, Pavel; Mutti, Luciano; Foddis, Rudy; Cristaudo, Alfonso; Gemignani, Federica; Landi, Stefano
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.
2014-01-01 Cipollini, Monica; Landi, Stefano; Gemignani, Federica
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk
2015-01-01 Figlioli, Gisella; Chen, Bowang; Elisei, Rossella; Romei, Cristina; Campo, Chiara; Cipollini, Monica; Cristaudo, Alfonso; Bambi, Franco; Paolicchi, Elisa; Hoffmann, Per; Herms, Stefan; Kalemba, Michal; Kula, Dorota; Pastor, Susana; Marcos, Ricard; Velázquez, Antonia; Jarzab, Barbara; Landi, Stefano; Hemminki, Kari; Gemignani, Federica; Försti, Asta
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
2014-01-01 Figlioli, G; Köhler, A; Chen, B; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Cristaudo, Alfonso; Bambi, F; Paolicchi, E; Hoffmann, P; Herms, S; Kalemba, M; Kula, D; Pastor, S; Marcos, R; Velázquez, A; Jarząb, B; Landi, Stefano; Hemminki, K; Försti, A; Gemignani, Federica
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma
2016-01-01 Cipollini, Monica; Figlioli, Gisella; Maccari, Giulia; Garritano, SONIA IOLANDA; DE SANTI, Chiara; Melaiu, Ombretta; Barone, Elisa; Bambi, F; Ermini, S; Pellegrini, G; Cristaudo, Alfonso; Foddis, Rudy; Bonotti, Alessandra; Romei, Cristina; Vivaldi, A; Agate, Laura; Molinari, E; Barale, Roberto; Forsti, A; Hemminki, K; Elisei, Rossella; Gemignani, Federica; Landi, Stefano
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma
2020-01-01 Gemignani, F; Romei, C; Ciampi, R; Corrado, A; Melaiu, O; Figlioli, G; Bonotti, A; Foddis, R; Cristaudo, A; Pellegrini, G; Vivaldi, A; Cipollini, M; Landi, S; Elisei, R.
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system
2021-01-01 Corrado, Alda; Aceto, Romina; Silvestri, Roberto; Dell'Anno, Irene; Ricci, Benedetta; Miglietta, Simona; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Garritano, Sonia; Giusti, Laura; Zallocco, Lorenzo; Elisei, Rossella; Landi, Stefano; Gemignani, Federica
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people | 1-gen-2014 | Garritano, SONIA IOLANDA; DE SANTI, Chiara; Silvestri, R; Melaiu, Ombretta; Cipollini, Monica; Barone, Elisa; Lucchi, Marco; Barale, Roberto; Mutti, L; Gemignani, Federica; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Landi, Stefano | |
| A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma | 1-gen-2016 | Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Melaiu, Ombretta; Cipollini, Monica; Bambi, Franco; Chen, Bowang; Köhler, Aleksandra; Cristaudo, Alfonso; Hemminki, Kari; Gemignani, Federica; Försti, Asta; Landi, Stefano | |
| Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma | 1-gen-2016 | Pellè, Lucia; Cipollini, Monica; Tremmel, Roman; Romei, Cristina; Figlioli, Gisella; Gemignani, Federica; Melaiu, Ombretta; DE SANTI, Chiara; Barone, Elisa; Elisei, Rossella; Seiser, Eric; Innocenti, Federico; Zanger, Ulrich M.; Landi, Stefano | |
| Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. | 1-gen-2017 | Cipollini, Monica; Landi, Stefano; Gemignani, Federica | |
| Correction: Inherited variants in genes somatically mutated in thyroid cancer | 1-gen-2018 | Campo, Chiara; Köhler, Aleksandra; Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Bambi, Franco; Hemminki, Kari; Gemignani, Federica; Landi, Stefano; Försti, Asta | |
| Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism | 1-gen-2017 | DE SANTI, Chiara; Melaiu, Ombretta; Bonotti, Alessandra; Cascione, Luciano; Di Leva, Gianpiero; Foddis, Rudy; Cristaudo, Alfonso; Lucchi, Marco; Mora, Marco; Truini, Anna; Tironi, Andrea; Murer, Bruno; Boldorini, Renzo; Cipollini, Monica; Gemignani, Federica; Gasparini, Pierluigi; Mutti, Luciano; Landi, Stefano | |
| Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma | 1-gen-2021 | Dell'Anno, I.; Martin, S. A.; Barbarino, M.; Melani, A.; Silvestri, R.; Bottaro, M.; Paolicchi, E.; Corrado, A.; Cipollini, M.; Melaiu, O.; Giordano, A.; Luzzi, L.; Gemignani, F.; Landi, S. | |
| Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma | 1-gen-2011 | Cancemi, Lisa; Romei, Cristina; Bertocchi, Sara; Tarrini, Giulia; Spitaleri, Irene; Cipollini, Monica; Landi, Debora; Garritano, Sonia; Pellegrini, Giovanni; Cristaudo, Alfonso; Pinchera, Aldo; Barale, Roberto; Elisei, Rossella; Landi, Stefano; Gemignani, Federica | |
| Expression status of candidate genes in mesothelioma tissues and cell lines | 1-gen-2015 | Melaiu, Ombretta; Melissari, E; Mutti, L; Bracci, E; DE SANTI, Chiara; Iofrida, C; Di Russo, M; Cristaudo, Alfonso; Bonotti, Alessandra; Cipollini, Monica; Garritano, Si; Foddis, Rudy; Lucchi, Marco; Pellegrini, Silvia; Gemignani, Federica; Landi, Stefano | |
| Genome-wide association study on differentiated thyroid cancer. | 1-gen-2013 | Köhler, A; Chen, B; Gemignani, Federica; Elisei, Rossella; Romei, Cristina; Figlioli, G; Cipollini, Monica; Cristaudo, Alfonso; Bambi, F; Hoffmann, P; Herms, S; Kalemba, M; Kula, D; Harris, S; Broderick, P; Houlston, R; Pastor, S; Marcos, R; Velázquez, A; Jarzab, B; Hemminki, K; Landi, Stefano; Försti, A. | |
| High prevalence of chromosome 10 rearrangements in human lymphocytes after in vitro X-ray irradiation | 1-gen-2000 | Scarpato, Roberto; Lori, A.; Tomei, ANTONIO EGIDIO; Cipollini, Monica; Barale, Roberto | |
| Inherited variants in genes somatically mutated in thyroid cancer | 1-gen-2017 | Campo, Chiara; Kohler, Aleksandra; Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Bambi, Franco; Hemminki, Kari; Gemignani, Federica; Landi, Stefano; Forsti, Asta | |
| Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines | 1-gen-2017 | Melaiu, Ombretta; Catalano, Calogerina; DE SANTI, Chiara; Cipollini, Monica; Figlioli, Gisella; Pellè, Lucia; Barone, Elisa; Evangelista, Monica; Guazzelli, Alice; Boldrini, Laura; Sensi, Elisa; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Mutti, Luciano; Fontanini, Gabriella; Gemignani, Federica; Landi, Stefano | |
| Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals | 1-gen-2017 | DE SANTI, Chiara; Pucci, Perla; Bonotti, Alessandra; Melaiu, Ombretta; Cipollini, Monica; Silvestri, Roberto; Vymetalkova, Veronika; Barone, Elisa; Paolicchi, Elisa; Corrado, Alda; Lepori, Irene; Dell'Anno, Irene; Pellè, Lucia; Vodicka, Pavel; Mutti, Luciano; Foddis, Rudy; Cristaudo, Alfonso; Gemignani, Federica; Landi, Stefano | |
| MicroRNA binding site polymorphisms as biomarkers in cancer management and research. | 1-gen-2014 | Cipollini, Monica; Landi, Stefano; Gemignani, Federica | |
| Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk | 1-gen-2015 | Figlioli, Gisella; Chen, Bowang; Elisei, Rossella; Romei, Cristina; Campo, Chiara; Cipollini, Monica; Cristaudo, Alfonso; Bambi, Franco; Paolicchi, Elisa; Hoffmann, Per; Herms, Stefan; Kalemba, Michal; Kula, Dorota; Pastor, Susana; Marcos, Ricard; Velázquez, Antonia; Jarzab, Barbara; Landi, Stefano; Hemminki, Kari; Gemignani, Federica; Försti, Asta | |
| Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. | 1-gen-2014 | Figlioli, G; Köhler, A; Chen, B; Elisei, Rossella; Romei, Cristina; Cipollini, Monica; Cristaudo, Alfonso; Bambi, F; Paolicchi, E; Hoffmann, P; Herms, S; Kalemba, M; Kula, D; Pastor, S; Marcos, R; Velázquez, A; Jarząb, B; Landi, Stefano; Hemminki, K; Försti, A; Gemignani, Federica | |
| Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma | 1-gen-2016 | Cipollini, Monica; Figlioli, Gisella; Maccari, Giulia; Garritano, SONIA IOLANDA; DE SANTI, Chiara; Melaiu, Ombretta; Barone, Elisa; Bambi, F; Ermini, S; Pellegrini, G; Cristaudo, Alfonso; Foddis, Rudy; Bonotti, Alessandra; Romei, Cristina; Vivaldi, A; Agate, Laura; Molinari, E; Barale, Roberto; Forsti, A; Hemminki, K; Elisei, Rossella; Gemignani, Federica; Landi, Stefano | |
| Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma | 1-gen-2020 | Gemignani, F; Romei, C; Ciampi, R; Corrado, A; Melaiu, O; Figlioli, G; Bonotti, A; Foddis, R; Cristaudo, A; Pellegrini, G; Vivaldi, A; Cipollini, M; Landi, S; Elisei, R. | |
| Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system | 1-gen-2021 | Corrado, Alda; Aceto, Romina; Silvestri, Roberto; Dell'Anno, Irene; Ricci, Benedetta; Miglietta, Simona; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Garritano, Sonia; Giusti, Laura; Zallocco, Lorenzo; Elisei, Rossella; Landi, Stefano; Gemignani, Federica |